A detailed history of Amalgamated Bank transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Amalgamated Bank holds 1,687 shares of ENOB stock, worth $7,760. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,687
Previous 1,687 -0.0%
Holding current value
$7,760
Previous $3,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
N/A
1,687 New
1,687 $3,000
Q1 2023

May 02, 2023

SELL
$0.91 - $1.31 $416 - $599
-458 Reduced 10.7%
3,821 $3,000
Q2 2022

Aug 15, 2022

BUY
$1.93 - $8.73 $8,258 - $37,355
4,279 New
4,279 $8,000

Others Institutions Holding ENOB

About Enochian Biosciences Inc


  • Ticker ENOB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,950,000
  • Market Cap $244M
  • Description
  • Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...
More about ENOB
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.